In the context of gemcitabine, the 5637GR bladder tumors had elevated expression of the OVOL1 target genes, including SOX2 and SOX9, in a OXCT1-dependent manner, resulting in greater mitotic index (Figure 8). Here, SOX9 is linked to urinary bladder neoplasm.